Why BioCryst Pharmaceuticals Stock Is Popping Today
Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) are rising sharply today following bullish commentary from a Wall Street analyst. The biopharmaceutical company's stock was up by 9.2% as of 1:11 p.m. EST, after jumping by as much as 10.6% earlier on Monday.
Cowen analyst Ken Cacciatore initiated coverage on BioCryst stock with an outperform (buy) rating. Cacciatore also gave the stock a price target of $16. Shares of BioCryst Pharmaceuticals closed Friday's trading at $10.78, and they are at $11.89 as of this writing. In other words, the analyst's price target represents a significant upside on the stock, even accounting for today's rally. Why is Cacciatore so enthusiastic regarding BioCryst Pharmaceuticals' prospects? In a word: Orladeyo.
Image source: Getty Images.
Source Fool.com
